A cohort study including 11 US hospitals and 232 patients with Vancomycin-resistant enterococci (VRE) showed an 18% mortality rate; failure of early eradication of VRE from the bloodstream was the strongest predictor of in-hospital mortality.

Contemporary Clinical and Molecular Epidemiology of Vancomycin-Resistant Enterococcal Bacteremia: A Prospective Multicenter Cohort Study (VENOUS I) – Open Forum Infectious Diseases

Commentary on Twitter

New in OFID: In a prospective cohort with enterococcal bloodstream infections, failure to eradicate vancomycin-resistant enterococci from the bloodstream early was a major factor associated with poor outcomes.

📄 https://t.co/I4hlelW2La@PaulSaxMD @DrJLi @FungalDoc @SuperBugDoc pic.twitter.com/m10YeVjUXw

— IDSA (@IDSAInfo) January 1, 2022